Mesoblast (MESO) EBT Margin (2014 - 2023)
Mesoblast's EBT Margin came in at -47.31% for the year ended Jun 30, 2026, up 544.69 percentage points from -592.00% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) EBT Margin (2014 - 2023) Analysis & Trends
Going back to the year ended Jun 30, 2015, Mesoblast's EBT Margin data covers 12 years.
- EBT Margin carries a five-year change of +1292.89 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 represents the highest annual EBT Margin in data going back to the year ended Jun 30, 2015.
- Per Business Quant, earlier years put EBT Margin at -592.00% in the year ended Jun 30, 2025 (+901.51 pp), -1493.51% in the year ended Jun 30, 2024 (-398.98 pp), -1094.53% in the year ended Jun 30, 2023 (-197.60 pp) and -896.93% in the year ended Jun 30, 2022 (+443.26 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Mesoblast | 1.66 Bn | 1.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -1,026.60% |
| Mar 31, 2023 | -961.63% |
| Dec 31, 2022 | -1,150.75% |
| Sep 30, 2022 | -1,127.01% |
| Jun 30, 2022 | -967.04% |
| Mar 31, 2022 | -1,061.51% |
| Dec 31, 2021 | -1,092.11% |
| Sep 30, 2021 | -631.80% |
| Jun 30, 2021 | -1,121.39% |
| Mar 31, 2021 | -1,359.19% |
| Dec 31, 2020 | -1,143.15% |
| Sep 30, 2020 | -1,936.70% |
| Jun 30, 2020 | -5,116.55% |
| Mar 31, 2020 | -141.12% |
| Dec 31, 2019 | -1,217.27% |
| Sep 30, 2019 | -43.50% |
| Jun 30, 2019 | -1,215.20% |
| Mar 31, 2019 | -2,175.74% |
| Dec 31, 2018 | -1,468.93% |
| Sep 30, 2018 | -173.66% |
API Access
Mesoblast EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();